Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Urabe

Showing results (241-250 of 251) with videos related to

Pageof 26
Sort By:
Biochemical and Biophysical Research Communications|June 15, 1995
Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colony-stimulating factorA Yuo, S Kitagawa, S Iki, et al.
International Journal of Hematology|May 25, 2001
Tyrosine phosphorylation of proteins in primary human myeloid leukemic cells stimulated by macrophage colony-stimulating factor: analysis by disease type and comparison with normal human hematopoietic cellsS Hagiwara, M Yagisawa, K Saeki, et al.
Experimental Hematology|January 1, 1997
Increased neutrophil respiratory burst in myeloproliferative disorders: selective enhancement of superoxide release triggered by receptor-mediated agonists and low responsiveness to in vitro cytokine stimulationS Iki, A Yuo, M Yagisawa, et al.
Annals of Hematology|November 1, 1996
Differentiation effect of acyclic retinoid on acute promyelocytic leukemia cellsK Usuki, A Urabe, A Tojo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 21, 2000
[A randomized trial of conventional dose vs reduced dose in BHAC-DM therapy for acute myelogenous leukemia in elderly patients]M Mori, H Nisimura, A Urabe, et al.
Thrombosis and Haemostasis|August 24, 1999
Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disordersA Matsumoto, T Tahara, H Morita, et al.
Oncology Reports|May 21, 2011
Clinical-study of multiple-myeloma in the elderlyJ Tomiyama, H Kudo, N Nakamura, et al.
Leukemia & Lymphoma|September 24, 1999
Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantationY Kanda, S Chiba, Y Tanaka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 1, 1996
Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseasesK Toyama, M Yaguchi, H Mizoguchi, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders]K Kitamura, K Miyagawa, A Urabe, et al.
Pageof 26

Showing results (241-250 of 251) with videos related to

Sort By:
Pageof 26
Biochemical and Biophysical Research Communications|June 15, 1995
Tyrosine phosphorylation of vav protooncogene product in primary human myelogenous leukemic cells stimulated by granulocyte colony-stimulating factorA Yuo, S Kitagawa, S Iki, et al.
International Journal of Hematology|May 25, 2001
Tyrosine phosphorylation of proteins in primary human myeloid leukemic cells stimulated by macrophage colony-stimulating factor: analysis by disease type and comparison with normal human hematopoietic cellsS Hagiwara, M Yagisawa, K Saeki, et al.
Experimental Hematology|January 1, 1997
Increased neutrophil respiratory burst in myeloproliferative disorders: selective enhancement of superoxide release triggered by receptor-mediated agonists and low responsiveness to in vitro cytokine stimulationS Iki, A Yuo, M Yagisawa, et al.
Annals of Hematology|November 1, 1996
Differentiation effect of acyclic retinoid on acute promyelocytic leukemia cellsK Usuki, A Urabe, A Tojo, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 21, 2000
[A randomized trial of conventional dose vs reduced dose in BHAC-DM therapy for acute myelogenous leukemia in elderly patients]M Mori, H Nisimura, A Urabe, et al.
Thrombosis and Haemostasis|August 24, 1999
Characterization of native human thrombopoietin in the blood of normal individuals and of patients with haematologic disordersA Matsumoto, T Tahara, H Morita, et al.
Oncology Reports|May 21, 2011
Clinical-study of multiple-myeloma in the elderlyJ Tomiyama, H Kudo, N Nakamura, et al.
Leukemia & Lymphoma|September 24, 1999
Increased serum soluble Fas ligand associated with recurrent B-cell non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantationY Kanda, S Chiba, Y Tanaka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|December 1, 1996
Effect of recombinant human granulocyte colony-stimulating factor on combination therapy with aztreonam and clindamycin for infections in neutropenic patients with hematologic diseasesK Toyama, M Yaguchi, H Mizoguchi, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders]K Kitamura, K Miyagawa, A Urabe, et al.
Pageof 26